Merck & Co as of June 30, 2026
Portfolio Holdings for Merck & Co
Merck & Co holds 13 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Ord (PSNL) | 35.8 | $188M | 14M | 13.40 | |
| Moderna (MRNA) | 30.7 | $162M | 2.3M | 70.03 | |
| Kymera Therapeutics (KYMR) | 16.8 | $89M | 772k | 114.67 | |
| Aktis Oncology (AKTS) | 5.8 | $31M | 953k | 32.23 | |
| Eikon Therapeutics (EIKN) | 4.1 | $22M | 1.7M | 13.05 | |
| Entrada Therapeutics (TRDA) | 2.4 | $13M | 1.7M | 7.36 | |
| Sutro Biopharma (STRO) | 1.7 | $9.0M | 272k | 33.20 | |
| Alector (ALEC) | 1.4 | $7.1M | 3.5M | 2.01 | |
| Evaxion Biotech A/s Sponsored Ads (EVAX) | 0.7 | $3.8M | 1.2M | 3.10 | |
| Miragen Therapeutics (VRDN) | 0.3 | $1.7M | 93k | 18.37 | |
| Xilio Therapeutics (XLO) | 0.2 | $1.0M | 106k | 9.58 | |
| Tuhura Biosciences (HURA) | 0.0 | $46k | 19k | 2.34 | |
| Neuphoria Therapeutics (NEUP) | 0.0 | $44k | 10k | 4.37 |
